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Open access under CC BAim of the study was to verify the clinical and morphological effects of intra-articular stanozolol or pla-
cebo treatment, lasting 3 and 9 months, in sheep in which a femoro-tibial osteo-arthritis (OA) were sur-
gically induced (medial bilateral meniscectomy).
Twenty healthy sheep divided into four groups and two control animals group, after surgical medial
bilateral meniscectomy, were weekly injected in femoral-tibial joint (FTJ) with stanozolol or placebo.
Lameness evaluation was performed and synovial ﬂuid was collected from all sheep at each treatment
time. Necropsies were performed after 3 or 9 month as described in experimental design. Gross pathol-
ogies were described and specimen tissues collected from femoro-tibial articular joints were processed
for routine histological examination.
The gross anatomy of the FTJ was well-preserved in stanozolol-treated sheep; this also applied to the
histological features of articular cartilage. Joint aseptic inﬂammation and ﬁbrosis were observed in pla-
cebo-treated sheep, associated with a different degree of severity of condylar and tibial plate cartilage
degeneration.
Stanozolol intra-articular treatment reduces osteophytes formation and subchondral bone reaction and
promotes articular cartilage regeneration.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
The pharmacological treatment of osteo-arthritis (OA) is an
ongoing challenge in equine clinical practice. Many treatments
have been proposed, including those tested in experimental and
clinical trials; however, response to treatment is not always satis-
factory (Goodrich and Nixon, 2006; Frisbie et al., 2009; Pearson
et al., 2009).
A variety of compounds used for the treatment of OA, including
steroidal and non-steroidal drugs, inhibitor of nitric oxide produc-
tion (NO) (Saleri et al., 2004). NO may be responsible for cartilage
destruction in OA (Blanco et al., 1995), by damaging chondrocyte
function, inhibiting collagen and proteoglycan synthesis, activating
metalloproteinase, decreasing the expression of IL-1 receptor
antagonist, inhibiting chondrocyte proliferation, and inducing
apoptotic death (Studer et al., 1999). Stanozolol is a synthetic deriv-
ative of testosterone; its properties include anabolic/androgenic
activity (Zannetti, 2004), probably associated with its afﬁnity for
androgenic and, at lower doses, glucocorticoid receptors (Fernandez
et al., 1994). Because of its strong anabolic effects, studies on the ef-: +39 0522 942412.
.G. Predieri).
Y-NC-ND license.fects of stanozolol treatment on OA are not performed in human
medicine (Belch et al., 1986; Ellis et al., 1994): the same promising
results (Zannetti, 2004; Dondi et al., 2008; Adamama-Moraitou
et al., 2009) has led to renewed interest in the use of the product
in veterinary medicine for companion animals.
Systemic stanozolol is used in horses as an anabolic steroid and
doping agent (Yamada et al., 2008; You et al., 2009). However, sta-
nazolol reduces apoptosis in equine chondrocytes in vitro, by
reducing the production of NO and stimulating IGF-1 production
(Saleri et al., 2004).
Lateral (Amstrong et al., 1994) or medial (Oakley et al., 2004)
sheep meniscectomy is considered the best widely used animal
model to investigate possible therapeutic approaches for degener-
ative joint disease in human and companion animals. Meniscec-
tomy induces lesions both in the articular cartilage and in
subchondral bone with the characteristic features of OA: articular
space narrowing, osteophyte formation, focal cartilage lesions
and decreased histochemical staining for proteoglycan (Moskowitz
and Goldberg, 1987; Moskowitz et al., 1979). The technique of
bilateral medial meniscectomy described by Oakley et al. (2004)
is considered the golden standard for experimental AO investiga-
tion. For these reasons this model has been considered ideal for
the present study.
380 A. Spadari et al. / Research in Veterinary Science 94 (2013) 379–387The aim of this study was to verify the clinical and morpholog-
ical effects of intra-articular treatment with stanozolol on surgi-
cally induced OA of the stiﬂe joints of sheep after 3 and
9 months of treatment.2 Nargesic, ACME, Cavriago (RE), Italy.
3 Ketavet, Intervet, Aptilia (LT), Italy.
4 IsoFlo, Abbot Laboratories Queenborought, Kent, United Kindom.
5 Vatamplius, FATRO, Ozzano dell’Emila (BO), Italy.
62. Materials and methods
The experiment was performed according to the legislative and
ethical requirements on animal care. The study protocol followed
the ‘‘Principles of good laboratory practice’’ of OECD (Organization
for Economic CO-operation and Development) and was approved
by the University of Bologna Ethics Committee (119-120/2004 C).
The experiment took place in the spring 2005.
2.1. Treatment preparation
The stanozolol1 suspension and placebo were produced accord-
ing to the following protocol: the test product was produced by add-
ing stanozolol to a sterile apyrogenic water suspension containing
sodium chloride and phosphate salts as a buffering system; the pla-
cebo did not contain any stanozolol molecules. The syringes were
ﬁlled of drug, or placebo, and capped in a sterile environment. Ana-
lytical controls of the product were carried out before use.
2.2. Animals and experimental design
Twenty, 1 year-old, female Bergamasca sheep, weighing
42.85 ± 3.7 kg, were used in the study.
Fifteen days before surgery, twenty sheep were housed in small
inside stalls with controlled temperature (18 C) and relative
humidity (70%); they were given a regular feeding regimen and di-
vided randomly into six groups: 4 groups of 4 animal each and two
groups of 2 animal each. Sixteen animals underwent bilateral med-
ial meniscectomy as described by Oakley et al. (2004). Sheep were
subjected to blood tests (hematological and biochemical proﬁle) to
verify their health status and orthopedic examination was per-
formed to exclude signs of lameness in the hind limbs. A radio-
graphic examination of the right and left stiﬂe was also
performed to rule out arthritic alterations of the stiﬂe before the
start of the study.
2.2.1. Group STAN3
Four sheeps (weighing 42.0 ± 1.4 kg) underwent meniscectomy
and were treated, 7 days post-surgery (p.s.), with weekly bilateral
FTJ (femoral-tibial joint) intra-articular administration of 1 mg of
stanozolol in 0.4 ml of aqueous suspension for three months. Sheep
were euthanized 3 months after the ﬁrst treatment applied 6 days
after meniscectomy.
2.2.2. Group MEN3
Four sheeps (weighing 42.0 ± 4.2 kg) underwent meniscectomy
and were treated 7 days p.s., with weekly bilateral FTJ intra-artic-
ular administration of placebo in 0.4 ml solution for three months.
The animals were euthanized 3 months after the ﬁrst treatment
applied 6 days after meniscectomy.
2.2.3. Group STAN9
Four sheeps (weighing 43.5 ± 0.7 kg) underwent meniscectomy
and were treated 7 days after the surgery, with weekly bilateral FTJ
intra-articular administration of a dose of 1 mg of stanozolol in
0.4 ml of aqueous suspension for three months and then every
two weeks for the following six months. Sheep were euthanized1 Megaxilor, Bio 98, Milan, Italy.9 months after the ﬁrst treatment applied 6 days after
meniscectomy.2.2.4. Group MEN9
Four sheeps (weighing 48.5 ± 2.1 kg) underwent meniscectomy
and were treated 7 days after the surgery, with weekly bilateral FTJ
intra-articular administration of placebo in 0.4 ml solution for
three months; then every two weeks over the next six months,
they were treated with placebo in 0.4 ml solution; the sheep were
euthanized 9 months after the ﬁrst treatment applied 6 days after
meniscectomy.2.2.5. Group CON1
Two sheeps (weighing 42.5 ± 2.1 kg) without meniscectomy,
were treated bilateral FTJ intra-articular administration of 1 mg
of stanozolol in 0.4 ml of aqueous suspension; one sheep CON(1–
3) received the same treatment plan and timing of the STAN3
and was euthanized at the same time as this group (after 3 months
of treatment); the other one CON(1–9) followed the same treat-
ment plan and timing of the STAN9 and was euthanized at the
same time as this group (9 months of treatment).2.2.6. Group CON2
Two sheeps (weighting 41 ± 1.4 kg) without meniscectomy
were treated bilateral FTJ intra-articular administration of placebo
in 0.4 ml solution; one sheep CON(2–3) received the same treat-
ment plan and timing of the MEN3 and was euthanized at the same
time as this group (3 months of treatment); one CON(2–9) fol-
lowed the same treatment plan and timing of the MEN9 and was
euthanized at the same time as this group (9 months of treatment).
To induce OA, sixteen sheep were subjected to open bilateral
medial meniscectomy under general anesthesia (premedication
with xylazine2 0.1 mg/kg im and butorphanol3 0.05 mg/kg im;
induction with ketamine4 2.2 mg/kg; maintenance with isoﬂurane5
and 100% O2) and dorsal recumbency.
Before the incision, a sample of synovial ﬂuid was taken from all
FTJ joints to determine normal baseline values. Post-surgery (p.s.)
sheep, stabled individually, were treated with ampicillin6 (20 mg/
kg, IM, q 12 h) and gentamicin7 (4 mg/kg, IM, q 24 h) and sheep ﬂu-
nixine meglumine8 (1 mg/kg, IM, q 12 h) ﬁve days p.s. Any bandage
was placed following surgery.
After a period of 30 days of conﬁnement in the stall, the 20
sheep were forced to walk in a paddock 50  50 m. Handlers forced
them to walk twice a day, at least for half-an-hour until the eutha-
nasia for all animals.
Treatment with stanozolol or placebo began at day six p.s. For
3 months, the 20 sheep received weekly intra-articular injections.
As described previously, after 3 months the sheep in groups
MEN3, STAN3 and CON1 (1–3) and CON2 (2–3) were euthanized.
The remaining sheep grouped in MEN9, STAN9 and CON1 (1–9)
and CON2 (2–9) were treated every two weeks for a further
6 months and subsequently euthanized.
The dosage and interval times between injections were based
on the results of an in vitro study on the effects of stanozolol on pri-
mary chondrocyte cultures (Saleri et al., 2004) and from a pharma-
cological study performed after intra-articular injection on sheep
to assess tolerability and pharmaco-kinetics (unpublished data).Aagent, FATRO, Ozzano dell’Emila (BO), Italy.
7 Meﬂosyl, Fortdodge, Aprilia (LT), Italy.
8 Tanax, Intervet International BV, Boxmeer, NL.
Table 1
Score used for reading the radiographs. From (Kellgren and Lawrence, 1957).
Score Description
0 None. Absence of X-ray changes of osteoarthrosis
1 Doubtful OA. In presence of moderate osteophytes
2 Minimal OA. Osteoarthrosis was present though the minimal severity
and deﬁnite osteophytes
3 Moderate OA
4 Severe. Multiple osteophytes, severe sclerosis and indeﬁnite bone
margins
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kg, IM); ketamine (3 mg/kg, IM) and Tanax9 (0.5 ml/kg, IV).
2.3. Assessment of clinical condition
Animals were observed on a daily basis to ensure that they were
eating, drinking regularly and moving. The hind limbs were exam-
ined and palpated regularly and the range of motion was evalu-
ated. Sheep in group CON1 (1–3), CON2 (2–3), MEN3, STAN3
were weighed at the third month; the sheep from groups CON1
(1–9), CON2 (2–9), MEN9, STAN9 were weighed at the third and
the ninth month.
2.4. Lameness
Weekly or every other week, before the injection (stanozolol or
placebo), sheep were checked for lameness and evaluated using
the score proposed for large animal lameness (Ross, 2003) adapted
for sheep.
The sheep were forced to walk ﬁrst and then to run and the
lameness score was determined by an expert veterinary orthopae-
dist (S.A.).
2.5. Radiological evaluation
All sheep underwent conventional radiological examinations
pre-surgery for inclusion in the experimental protocol; this was re-
peated at the end of the third month for all of the groups, while
groups CON1 (1–9), CON2 (2–9), MEN9 and STAN9 did the evalua-
tion after nine months again.
Radiographs were performed with handle restrain of the sheep
in two conventional projections for stiﬂe joint.
Diagnostic image evaluation was performed by two expert
orthopaedic veterinarians (A.S.; N.R.) blinded to the treatment
group, according to the score proposed by Kellgren and Lawrence
(1957) for radiographic assessment of OA severity (Table 1).
2.6. Synovial ﬂuid
Synovial ﬂuid (SF) was aseptically collected before each treat-
ment time from all sheep restrained in lateral recumbency with a
22G needle from the medial or lateral femoro-patellar pouch.
Immediately after synovial ﬂuid collection, smears were performed
for cytological examination. The smears (air-dried) were stained
using the May-Grunwald-Giemsa method, examined with a Nikon
Eclipse E800 microscope and images were captured by an Image
Analyzer.10,11
The synovial ﬂuid was also put in cryo-vials with the addition of
EDTA. Then were centrifuged at 2000 rpm for 10 min and the9 Sungate, ACME, Cavriago (RE), Italy.
10 Nikon digital sight, Nikon Corporation, Calenzano (FI), Italy.
11 Sigma Aldrich Srl, Milan, Italy.supernatants were frozen at 20 C until determination of the gly-
cosaminoglycans (GAGs) concentration according with previously
papers (Farndale et al., 1982, 1986).
2.7. Gross pathology, histopathology and tissue processing
Sheep’s necropsies were performed immediately after pharma-
cological euthanasia. Stiﬂe joints were examined and specimens
from synovial membrane were ﬁxed in 10% phosphate buffered
formaldehyde (pH 7.4), whereas specimens of articular cartilage,
from tibial and femoral condyles, were collected and simulta-
neously ﬁxed-decalciﬁed using a double step system. Specimens,
3–5 mm thick, were placed in Decalciﬁer-I (Surgipath) overnight
to ﬁx and perform decalciﬁcation, using the decalciﬁcant at a sam-
ple:volume ratio of 1:20. Overnight decalciﬁcation was performed
at room temperature, with gentle agitation. Specimens were then
directly transferred, without washing, into Decalciﬁer-II (Surgi-
path) to complete demineralization. Soft and decalciﬁed tissues
were embedded in parafﬁn wax (56–58 C, 08-7910 Bio-Optica,
Italy) by using a Vacuum Tissue Processor (Renaissance Ventana).
Five lm thick parafﬁn sections were obtained using a Rotary
microtome Leica RM2155 and stained for histological routine
methods (H&E, Masson’s trichrome stain).
Histological sections were analysed using a Nikon Eclipse E800
microscope and images were captured by an Image Analyzer.10,11
To process the data obtained from the study of macroscopic le-
sions found in synovial joints (SJs) of sheep killed three or nine
months after meniscectomy, the score of the International Journal
of Cartilage Repair Society (ICRS), reported below, was used
(Table 2).
2.8. GAGs determination in articular cartilage
At the end of the 3- and 9 month-experimental period, after
removing the periarticular soft tissue, the stiﬂe joints were opened
and full-depth plugs of condyle articular cartilage were obtained
by means of 6 mm punch. The cartilage plugs were promptly
weighed (fresh weight) and then dehydrated at 60 C for 20 h.
The dehydrated cartilage disks were weighed (dried weight),
placed into vials containing 1.0 ml of papain solution (50 mM
Tris–HCl pH 8, 1 mM EDTA, 2 mM dithiothreitol and 0.3 mg/ml pa-
pain) and were incubated at 65 C until complete tissue digestion.
The reaction was stopped with 50 mM iodoacetic acid in 2.5 mM
NaCl. A DMMB solution (2.5 ml) was added to 200 ll of each sam-
ple and to 200 ll of each standard (obtained as above mentioned);
the absorbance was measured at 525 nm by using a spectropho-
tometer (Perkin Elmer Lambda 25UV/Vis). The GAG content was
calculated from the standard curve obtained and was reported as
mg of GAGs/mg of dried tissue.
2.9. Statistical analysis
Descriptive statistics were applied to analyze the clinical and
non-parametric data.
The data obtained from lameness evaluation, the results from
radiological imagines evaluation and the body weight were ana-
lyzed with no-parametric test Mann Whitney with signiﬁcance
for P < 0.05 and high signiﬁcance for P < 0.01.
The results obtained from the gross evaluation of synovial ﬂuid
analysis were compared among the groups using Fisher’s exact test
with signiﬁcance at P < 0.05 and high signiﬁcance for P < 0.01.
Statistical analysis was performed on gross pathology. Data
were analyzed by Mann Whitney ‘‘U’’ test for different in medians:
Due to the low number of sheep, and in order to achieve an accept-
able power of the test, the analysis was performed for the six
Table 2
The score of the International Journal of Cartilage Repair Society (ICRS).
Grade Description of macroscopic lesions of articular cartilage (From International Cartilage Repair Society (ICRS)
http://www.cartilage.org/_ﬁles/contentmanagement/ICRS_evaluation.pdf)
0 Normal cartilage
1 Superﬁcial abnormalities: soft indentation (A) and/or superﬁcial ﬁssures and cracks (B)
2 Superﬁcial ﬁbrillation: ﬁssures are extended down to 50% of cartilage thickness
3 Deep ﬁbrillation: ﬁssures are extended down almost all/all the thickness of cartilage. (A) as well as down to calciﬁed layer (B) and down to but not
through the subchondral bone (C). Blisters are included in this Grade (D)
4 Exposed bone (the cartilage is completely eroded and subchondral bone is exposed)
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Fig. 1. Radiological images of the left FTJ, dorso-plantar view: (a) CON1–3; radiological score 0; (b) CON2–9 radiological score 0; (c) MEN3; (d) MEN9; (e) STAN 3; (f) STAN 9.
All the images was detected at the end of the protocol before the euthanasia.
Table 3
Results of macroscopic evaluation at 3 months of the joints in all groups.
Macroscopic score 3 months after surgery
Joint STAN 3 MEN3 CON1 CON2
Sheep Sheep Sheep Sheep Sheep Sheep Sheep Sheep Sheep Sheep
Right limb Femoral condyle 2 2 2 3 3 3 2 4 2 1
Trochlea 3 3 3 4 4 4 4 4 3 3
Tibial plateau 1 2 3 3 2 2 1 4 0 0
Left limb Femoral condyle 2 3 3 3 3 4 3 3 2 0
Trochlea 0 3 3 3 4 4 4 4 2 3
Tibial plateau 1 2 3 2 2 3 1 2 0 0
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3 months, STAN9, MEN9, CON1 and CON2 at 9 months).3. Results
3.1. Clinical condition
During the ﬁrst month p.s. 3 sheep (2 MEN3, 1 MEN9) showed
episodes of difﬁculty in standing up and one sheep of STAN3 group
showed p. s. signs of right radial nerve paresis. By the end of the
ﬁrst month these symptoms had disappeared in the three sheep.
Some animals had a mild rise in body temperature (>38.5 C) in
the ﬁrst days p. s. Moderate inﬂammation with serum-hemor-
rhagic subcutaneous swelling at the sutures occurred in three
sheep: in the right joint of a MEN3 animal and in both legs of
two MEN9 sheep. No other major variation in body conditions con-
cerning local pain or swelling of the knees were detected. Twosheep in the MEN9 group suffered monolateral left medial patellar
sub-luxation only in the ﬁrst three weeks p.s.3.2. Weight
The weight of sheep were measured pre-operatively and
ante-mortem with an increase of weight three months after men-
iscectomy of 0.80% for the sheep of MEN3 group (42.4 ± 4.8 kg pre
mortem) and 6.39% for the sheep of the group STAN3 (45.8 ± 3.8 kg
pre mortem), and after nine months 21% increase for MEN9
(55.5 ± 6.8 kg pre mortem) and 32.7% for STAN9 (62.0 ± 4.6 kg pre
mortem). In both CON group the mean increase of weight was 1.2%.3.3. Lameness evaluation
Groups STAN3 and STAN9 showed a lower overall lameness
score than groups MEN3 and MEN9. The groups were paired
384 A. Spadari et al. / Research in Veterinary Science 94 (2013) 379–387(MEN3 vs STAN3 and MEN9 vs STAN9) to compare the results, with
each group also having its control sheep (CON2–3 and CON1–3,
CON2–9 and CON1–9). From the comparison of the scores between
the paired groups, a lower grade of lameness was detected in the
STAN groups. The difference between the STAN and MEN groups
was statistically signiﬁcant only at week 1 and 10 (p < 0.05) for
the 3-months groups (STAN3 vs MEN3) while only at week 2
(p < 0.05) for the 9-months groups (STAN9 vs MEN9).3.4. Radiological evaluation
The features of OA observed in the radiographic images (Fig. 1)
had a slightly arthritic change after three months (radiological
score MEN 3 1.75 ± 1.1 and STAN 3 1.4 ± 0.7), that was more con-
sistent at nine months (radiological score MEN9 2.6 ± 1.2 and STAN
9 1.5 ± 0.7) in all meniscectomized sheep (16/20). Comparing the
scores between the paired groups, the difference between MEN 9
and STAN 9 was statistically signiﬁcant (p < 0.05).3.5. Cytomorphology
Arthrocentesis was unsuccessful in many cases; consequently it
was not possible to describe the cytology for every time-point in
the experimental design. Over the ﬁrst 3 months, of the 192 arthro-
centesis procedures completed on the MEN3 and MEN9 groups, 87
synovial ﬂuid samples were obtained; in the STAN3 and STAN9
groups 65/192 synovial ﬂuid samples were collected. In the subse-
quent 6 months, of the 96 arthrocentesis procedures completed on
the MEN9 and STAN9 groups, 23/96 and 21/96 synovial ﬂuid sam-
ples were collected, respectively. In the cases for which synovialFig. 2. 1 – Hyperplasia of synoviocytes: polipoides proliferations. (sheep CON3); 2 – H
chondrocytes (sheep STAN3); 4 – second level lesion (femoral condyles sheep STAN3); 5
MEN9); 7 – ﬁrst level lesion (sheep STAN3); 8 – third level lesion (sheep MEN9); 9 – foﬂuid smears were prepared, no pathological cellularity resembling
inﬂammation or allergy patterns were observed in sheep from the
STANs groups. The most common feature was mild exfoliation of
synoviocytes and the occasional presence of erythrocytes, probably
were related to the sample invasive collection technique. In the
CON and MEN groups, the cytomorphological pattern was very
similar to the STANs group.3.6. Gross pathology
Necroscopies were performed and no evidence of gross pathol-
ogies were recorded in organs, apparatuses and systems contained
in the neuro-cranial, thoracic and abdominal cavities.
FTJ lesion scores and descriptions are summarized in Table 3
and Table 4. A value from 0 to 4 of increasing grade of severity,
depending on the depth and extent of the skeletal lesion, was as-
signed to each animal.3.6.1. Three months
In sheep CON1–3 normal gross morphology was recorded in the
FTJ cartilage, whereas a histological aseptic inﬂammation and
ﬁbrosis were observed in sheep CON2–3.
In group MEN3, synovial ﬁbrosis, condylar and tibial plate car-
tilage degeneration were recorded at histological examination.
In group STAN3, condylar (Fig. 2(4)) and tibial plate cartilage
degeneration were histologically recorded but less severe com-
pared sheep in group MEN 3.
Grade 4 was frequently recognized in sheep group MEN 3 but
only one sheep in the STAN3 group showed comparable lesion
scores (Table 2).yperplasia of synoviocytes: regular distribution. (sheep STAN3); 3 –Proliferation of
– third level lesion (trochlea sheep MEN9); 6 – fourth level lesion (left joint sheep
urth level lesion (sheep MEN3).
Table 4
Results of macroscopic evaluation at 9 months of the joints in all groups.
Macroscopic score 9 months after surgery
Joint STAN 9 MEN9 CON1 CON2
Sheep Sheep Sheep Sheep Sheep Sheep Sheep Sheep Sheep Sheep
Right limb Femoral condyle 2 2 2 3 3 4 3 4 1 1
Trochlea 4 4 4 4 4 4 4 4 2 3
Tibial plateau 3 3 3 3 3 4 4 4 0 2
Left limb Femoral condyle 2 3 3 3 4 4 2 4 1 1
Trochlea 4 4 4 4 4 4 4 4 2 3
Tibial plateau 2 3 3 2 3 4 4 3 0 1
Table 5
Statistics analysis of the score of gross pathology in 3 months groups.
3 months
Two sample test record
Group Count Mean S.D. Power Prob level
MEN 3 vs CONS 24 3.08 1.02 0.99 0.00
12 1.33 1.30
STAN 3 vs CONS 24 2.45 0.88 0.84 0.01
12 1.33 1.30
STAN 3 vs MEN 3 24 2.45 0.18 0.60 0.02
24 3.08 0.2
Table 6
Statistics analysis of the score of gross pathology in 9 months groups.
9 months
Two sample test record
Group Count Mean S.D. Power Prob level
CONS vs MEN 9 12 1.41 0.99 1.00 0.00
24 3.700 0.55
CONS vs STAN 9 12 1.41 0.99 0.99 0.00
24 3.08 0.75
MEN vs STAN 9 24 3.70 0.55 0.88 0.00
24 3.08 0.77
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and CONs is summarized in Table 5 and has shown: STAN3 vs.
MEN3 p = 0.02; STAN3 vs CON1/2–3 p = 0.01 and MEN3 vs CON1/
2–3 p = 0.00.3.6.2. Nine months
In sheep CON1–9 normal FTJ gross morphology was recorded in
the stiﬂe cartilage and synovial capsule whereas cartilage degener-
ation was recorded in sheep CON2–9.
In sheep of group MEN9, synovial ﬁbrosis, condylar and tibial
plate cartilage degeneration were histologically observed. Gross
pathology of lateral condyle of the femur also showed clear struc-
tural deformation of the surface proﬁle with lateral tibio-femoral
anatomical incongruence (Fig. 2(6)).
Less severe, but identical lesions were recorded in sheep of
group STAN9.
Gross pathology of FTJs, developed during nine months follow-
ing meniscectomy, were evaluated in each sheep.
The lesions observed in FTJ of sheep 9 months after meniscec-
tomy were more severe in sheep of group MEN 9 compared to
sheep of group STAN 9, despite highlighting a general framework
for extremely serious lesions (MEN9).
Lesions of the tibial plateau were less severe, recording rather
low scores in all groups; cartilage ﬁbrillation was the mostfrequently observed histological feature, and was more severe in
sheep of group MEN.
The femoral trochlea of sheep of MEN9 and STAN 9 groups was
the anatomical surface that suffered the worst damage after sur-
gery. Moreover, the most severe lesions were seen in FTJs in sheep
of group MEN 9. In particular, large areas affected by erosion
involving the entire cartilage thickness reaching the subchondral
bone, phenomena of intense vertical ﬁbrillation and osteochondro-
phyte formation were observed (Fig. 2(5)). In reference to the latter
data, a better score was given to animals of STAN9 group.
Statistical analysis performed between the groups MEN9,
STAN9 and CON1–2 9 months is summarized in Table 6 and has
shown: STAN9 vs MEN9 p = 0.00; STAN9 vs CON1/2–9 p = 0.00
and MEN9 vs CON1/2–9 p = 0.00.3.7. Histopathology
For the sheep in group CON1–3 months, microscopic lesions
were not observed in the synovial membrane or in articular carti-
lage of FTJ, whereas in sheep CON2–3 an aseptic inﬂammation and
ﬁbrosis were observed.
In sheep CON1/2–9 months a mild synovial membrane aseptic
chronic inﬂammation as well as focal cartilage degeneration were
observed. These lesions are induced by the numerous intrarticular
sampling collection as indicated in experimental design.
In the sheep of group MEN3, synovial aseptic inﬂammation was
observed in association with synovial ﬁbrosis. In groups MEN3 and
STAN3, slight synoviocytes hyperplasia was recorded. In group
MEN3, the synovial membrane showed an irregular proﬁle with
invaginations and the corion was ﬁbrotic. Synoviocytes showed
hyperplasic features characterized by proliferation of clusters ar-
ranged in polypoid shape (Fig. 2(1)).
In sheep of STAN3 (Fig. 2(2)) and STAN9 groups, the synovial
membrane showed a straight proﬁle and synoviocytes hyperplasia
which covered regularly the surface of synovial membrane.
Fibrillation of cartilage and thinning of the femoro-tibial articu-
lar cartilage plates accompanied by chondrocytes hyperplasia,
were observed in sheep of groups STAN3 (Fig. 2(7)) MEN9
(Fig. 2(8)) and MEN3 (Fig. 2(9)).
In sheep of group STAN3 chondrocytes regeneration, arranged
in clusters were very prominent (Fig. 2(3)).3.8. GAGs determination in the synovial ﬂuid
The analysis of the synovial ﬂuid for the determination of GAGs
during the ﬁrst 3 months highlighted a variable and irregular
course in groups MEN3 and STAN3. Regarding group MEN3, a
reduction for GAGs was observed during the ﬁrst week post-sur-
gery. This was followed by erratic changes in the 3rd week. From
4 to 12 weeks the course was more constant and characterized
by values of 5 lg/100 ll that progressively decreased up to 2 lg/
100 ll at 22 weeks. Regarding groups STAN3 and STAN9, the
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9 weeks were observed together with a strong decrease at 8 weeks.
Between 10 and 23 weeks, the curve was comparable to that ob-
served in group MEN9 a trend to decrease of the GAGs amount.
However, the trend was similar in both groups and the major dif-
ference was observed at 6 and 11 weeks. Statistical analyses was
not applied because of the limited numbers of sample.3.9. GAGs determination in articular cartilage
Any signiﬁcant differences were observed in the cartilage GAGs
content among considered groups nor at three months neither nor
at nine months of treatments.4. Discussion
The morphological and histological changes in cartilage, sub-
chondral bone and surrounding articular tissues observed in the
ovine joints following meniscectomy are considered a good repre-
sentation of induced OA.
When the study was designed, it was essential to produce a
complete ‘‘expert,’’ overview including the clinical report, to pres-
ent to the National Pharmacological Authority; the study aimed to
collect data useful to license a trademark for the drug. The whole
process required ﬁve years and it was not possible to publish par-
tial data throughout this period. Of the animal models presented in
literature, the bilateral medial meniscectomy followed by forced
walking for different periods, appeared to be most appropriate
for the purposes of the research. The creation of a bilateral lesion
in the knees avoided the protective effect sustained by the sound
hind limb and the controlled, progressive effect of the instability.
The joint damage was expressed to a greater degree on the medial
side because of the meniscal removal, accompanied by the
mechanical stress prevalence of medial weight bearing; it pro-
moted the progress of the features of OA in the short term. The
medial articular surfaces had the most severe degenerative
changes with development of chondro-osteophytes not clearly evi-
dent at radiological examination (lateral view), while the lateral
compartment of the joint, after a period of rapid modiﬁcations, sta-
bilized with less progressive and more linear changes. For the dif-
ferent characteristics of pathological changes inside the joint
obtained in the short and long term, the model proved to be ideal
for studying the progression of the pathology and outlined the
capability of the structure-modifying drugs for OA that could have
rapid onset of action and a long-lasting effect.
Using this model the counteracting effects of the stanozolol on
the degenerative changes were observed with a series of clinical
and morphological evaluations 3 and 9 months p.s. Moreover
sheep demonstrated to be good patients and ideal candidates for
this type of experimental work, because of their docile nature
and pliant behavior, despite the complex and demanding study
protocol.
The different gain in body weight observed between animals
treated with stanozolol and placebo is not thought to be related
to the anabolic effect of the drug. The dosage of 1 mg intraarticu-
larly of stanozolol is considerably lower than the normal values
for the anabolic effect indicated in literature – about 10 mg/kg
once a week in man (Small et al., 1984). In a previous clinical work
on 15 dogs systemically treated for tracheal collapse with a dose of
0.3 mg/kg, IM, q 24 h of stanozolol, no changes to the sexual
characteristics or muscular hypertrophy typical of the anabolic/
androgenic side effects were detected (Dondi et al., 2002;
Adamama-Moraitou et al., 2009).
In both CON groups the weight increase was poor; it was sug-
gested that the weight gain observed in the sheep of group STANscould be due to better soundness that lead to better body condi-
tions, more movement and hierarchical predominance of these ani-
mals for feed.
It was also suggested that positive effects of stanozolol on car-
tilage could be attributed to an anti-dystrophic effect, different to
the ‘‘classical’’, more well-known anabolic action (Fernandez
et al., 1994).
This was explained because stanozolol, unlike natural andro-
genic molecules, may interact with the Type I androgenic receptors
(AR) that also include receptors for glucocorticoids, mineralcortic-
oids and progesterone. Stanozolol has high afﬁnity for these recep-
tors and at low dosages is able to block glucocorticoid receptors,
hindering progesterone activity and the catabolic effects of gluco-
corticoids, before showing the anabolic effect and activating the
AR (Wright et al., 1989). In fact side effects associated to the sys-
temic administration of stanozolol at high dosages or for prolonged
periods cannot be excluded.
Accuracy in lameness evaluation was difﬁcult because of the
impossibility to lead the animals and because of their sudden
and irregular movements. Despite this the AAEP scale adapted
quite well to the study needs. Lameness was inserted in the proto-
col as one of the parameters that could produce a clinical overview
on the effects of the treatment. The data of lameness evaluation be-
tween groups STAN9 and MEN9 was not statistically signiﬁcant.
However the apparent results observed of mean data lameness
score could suggest a positive response regarding the efﬁcacy of
the stanozolol treatment. It should be mentioned that two of the
sheep in the group MEN9 had patellar sub-luxation that recovered
after some weeks, even if it is considered to have little inﬂuence in
pathological OA development, as observed in a canine osteoar-
thritic and arthritic joint study (Hegemann et al., 2002).
The results from radiological examination had to be compared
with the morphological ones reported in the gross pathology. In
the radiographs taken 3 months p.s. some limited features of OA
were observed, with no signiﬁcance between the groups (MEN3
and STAN3) as well as in the others (MEN9 and STAN9). Findings
at 9 months (MEN9 and STAN9) showed statistical signiﬁcance,
probably due to the slower progression of the pathology in the ani-
mals in STAN9. These results were also supported by the gross
pathology as well as histopathology features.
Histological examination of the articular cartilage highlighted
synoviocytes hyperplasia and clusters of regenerative chondro-
cytes in sheep of group STAN3 vs groups MEN3 and CONs.
Reactive synovial regular hyperplasia was more evident in
groups STAN3 and STAN9 than in groups MEN3 and MEN9. This
hyperplastic response persists and is partly due to adaptation le-
sions from the persistent damaging element (thinning of articular
cartilage).
Gross and histopathological investigations demonstrated toler-
ability of the stanozolol molecule in the articular environment but
also highlighted its pharmacological activity by inducing synovial
membrane regular hyperplasia and articular cartilage regenera-
tion. Of particular relevance was the fact that chondro-synovio-
cytes hyperplasic-reactive phenomena were observed in a
validated experimental model that produced serious acute and
chronic joint injuries, because of the constant traumas induced
by the alteration of joint mechanics.
The synovial ﬂuid sampling was not possible at every visit. In
the ﬁrst months we witnessed a decreased number of samples in
the STAN groups compared to number from the MEN ones. It
was suggested that the reduced inﬂammatory phase in STAN
groups could have resulted in less ﬂuid forming in the joint.
Synovial ﬂuid cytologic data allowed observation of inﬂamma-
tory cells (neutrophils and lymphocytes) and/or cells derived from
synovial membrane (synoviocytes) without showing features of
adverse cellular reaction.
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action, one study (Falanga et al., 1998) demonstrated that stanozo-
lol was able to induce ﬁbroblasts to increased collagen production
in a dose-dependent pathway by means of TGF-b1 synthesis. The
TGF-b1 effects are complex, variable, and cell line-dependent but
ultimately increase cellular matrix production (Wright et al.,
1989).
One of the main effects of stanozolol on in vitro-cultured chon-
drocytes is a signiﬁcant reduction of NO production and stimula-
tion of autocrin secretion of IGF-I (Saleri et al., 2004).
Differently to a previous report (Oakley et al., 2004) that fo-
cused on the assessment of bone mineral density, cartilage and
subchondral bone thickness, the present study concentrated lar-
gely on the effects of the stanozolol on the synovial lining and
cartilage.
The morphological changes associated with induced OA, such as
osteophytes and cartilage and subchondral bone reaction could
represent a physiological response with adaptive remodeling to
abnormally distributed mechanical stresses (Hwa et al., 2001) or
a different pathway of cytokine expression.5. Conclusions and clinical relevance
The use of stanozolol in this model of OA in sheep did not pro-
duce any joint reaction even after repeated injections. Compared to
the controls, it reduced the formation of osteophytes and subchon-
dral bone reaction, in consideration of the morphological changes
associated with induced OA. The features observed in articular car-
tilage demonstrate a valid and organized chondral matrix articular
regeneration with a normal morphological structure. The results
obtained with this pilot experimental study allow us to transfer
the experience to clinical trials in the target veterinary species –
such as horse and dog – affected by the spontaneous osteo-
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